Cardiology Search
Cardiology Cardiology
peripheral%20arterial%20disease
PERIPHERAL ARTERIAL DISEASE
Peripheral arterial disease includes a range of vascular syndromes caused by atherosclerosis and thromboembolic pathophysiological processes that alter the normal structure and function of the aorta, its visceral arterial branches and the arteries of the lower extremity.
Individuals at risk for lower extremity peripheral arterial disease should undergo review of vascular symptoms and comprehensive vascular examination to assess walking impairment, claudication, ischemic rest pain and/or the presence of nonhealing wounds.
Patients with peripheral arterial disease may be symptomatic or asymptomatic. Symptoms may range from claudication presenting as exertional leg pain to chronic limb-threatening ischemia presenting as rest pain, ulceration or gangrene.

Peripheral Arterial Disease Drug Information

Drug Information

Indication: Essential HTN.

Indication: Thrombolytic treatment in acute MI, acute massive pulmonary embolism w/ haemodynamic instability & of acut...

Atozet
atorvastatin + ezetimibe

Indication: Reduced risk of CV death, nonfatal MI & stroke, hospitalization for unstable angina or need for revascular...

Indication: Adjunct to diet for patients w/ elevated total cholesterol (total-C) & LDL-cholesterol (LDL-C), apolipopro...

Indication: Thrombolytic treatment of acute MI. Treatment initiated as soon as possible after symptom onset.

Indication: Essential HTN. Reduction of the risk of MI, stroke or death in patients ≥55 yr at high risk developing majo...

Indication: Essential HTN when BP is inadequately controlled by monotherapy w/ telmisartan.

Indication: Prophylaxis of migraine w/ or w/o aura. Symptomatic treatment of vestibular vertigo, due to a diagnosed functi...

Indication: Maintenance therapy for symptoms of cerebrovascular origins, labyrinthine & peripheral-circulatory disorde...

Indication: Primary hypercholesterolemia: Adjunctive therapy to diet for the reduction of elevated total cholesterol (tota...

1  /  9
1  /  9
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Finerenone reduces CKD progression, CV risk
Roshini Claire Anthony, 11 Dec 2020

Treatment with the nonsteroidal, selective mineralocorticoid receptor antagonist finerenone reduced chronic kidney disease (CKD) progression and cardiovascular (CV) event risk in patients with CKD and type 2 diabetes (T2D), according to the FIDELIO-DKD* study presented at ASN Kidney Week 2020.
High intakes of egg, fish, dairy products may protect women against CVD
Stephen Padilla, 22 Jun 2020
A dietary pattern (DP) characterized by high intakes of eggs, fish, milk, and other dairy products appears to confer protective benefits against incident cardiovascular disease (CVD) in women, reveals a study.